BioPet Laboratories is a biotechnology company focused on the field of animal genomics. The company offers a range of products and services, including PooPrints, a DNA solution for dog waste management, BioPet Life Plan, an interactive tool for canine health and wellness management, DNA Proof of Parentage certification, Travel Dog, an elite club for dogs and their owners, and the DNA World Pet Registry, a database for storing canine genetic information. As the parent company of the PooPrints program, BioPet collaborates with over 7,000 multifamily properties globally and has a database of more than 800,000 individual canines, establishing itself as an industry standard for canine genetics. Furthermore, BioPet Laboratories is accredited to the ISO/IEC 17025:2017 standard. Founded in 2008, the company has been a pioneer in offering competitive pricing and fast processing times in canine paternity testing. With a strong track record in canine DNA analysis, parentage verification, and DNA matching of fecal samples, BioPet is continually expanding its offerings in genetics and forensics. The company's emphasis on innovation, industry impact, and quality standards positions it as a notable player in the biotechnology sector.
There is no investment information
No recent news or press coverage available for BioPet Laboratories.